Literature DB >> 10938988

Differential diagnosis and secondary causes of osteoporosis.

P Taxel1, A Kenny.   

Abstract

Secondary osteoporosis refers to osteoporosis in which an underlying cause or factor other than those attributable to the postmenopausal state or aging can be identified. Primary, or idiopathic, osteoporosis implies that a secondary cause cannot be found. Secondary osteoporosis occurs not only in postmenopausal women but also in men and premenopausal women. In series reported from specialized centers, as many as 30% of postmenopausal women and 50% to 80% of men have an identifiable secondary cause of osteoporosis, although the frequency of secondary osteoporosis is probably much lower in the general population. In assessing the patient with osteoporosis, it is important to look for secondary causes and aggravating factors that are reversible and amenable to therapy. In addition to secondary forms, 2 metabolic bone diseases, osteomalacia and primary hyperparathyroidism, can mimic or aggravate osteoporosis. This paper will summarize the differential diagnosis and management of osteoporosis, osteomalacia, and hyperparathyroidism and review the most common causes of secondary osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938988     DOI: 10.1016/s1098-3597(00)90002-4

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  6 in total

1.  Paleopathological findings in radiographs of ancient and modern Greek skulls.

Authors:  Manolis J Papagrigorakis; Kostas G Karamesinis; Kostas P Daliouris; Antonis A Kousoulis; Philippos N Synodinos; Michail D Hatziantoniou
Journal:  Skeletal Radiol       Date:  2012-05-19       Impact factor: 2.199

2.  Two patients with osteoporosis: initial presentation of systemic mastocytosis.

Authors:  Marjolein L Donker; Nicolaas A Bakker; Wim J M Jaspers; Albert H Verhage
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

3.  Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.

Authors:  T-L Chung; N-C Chen; C-L Chen
Journal:  Osteoporos Int       Date:  2018-08-31       Impact factor: 4.507

Review 4.  Diseases affecting bone quality: beyond osteoporosis.

Authors:  Aasis Unnanuntana; Brian J Rebolledo; M Michael Khair; Edward F DiCarlo; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

5.  The value of laboratory tests in diagnosing secondary osteoporosis at a fracture and osteoporosis outpatient clinic.

Authors:  Gijs de Klerk; J Han Hegeman; Detlef van der Velde; Job van der Palen; Leo van Bergeijk; Henk J Ten Duis
Journal:  Geriatr Orthop Surg Rehabil       Date:  2013-06

Review 6.  The osteocyte as a therapeutic target in the treatment of osteoporosis.

Authors:  Gaël Y Rochefort
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.